Harvard Bioscience (HBIO) announced the resignation of Jennifer Cote, the company’s CFO and Treasurer. Cote’s resignation will be effective upon the filing of the company’s Quarterly Report on Form 10-Q, which is expected to be filed on or before May 12. The company has appointed Mark Frost as its Interim CFO and Treasurer effective upon Cote’s resignation. Frost brings over 30 years of financial and executive-level management experience from both private and public companies. He has served as a consultant to the company since January. Frost previously served as the CFO of Fathom, a digital manufacturing company providing prototype and bridge production capability to accelerate new product development for Fortune 500 companies.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- Harvard Bioscience downgraded to Sector Weight from Overweight at KeyBanc
- Harvard Bioscience price target lowered to $4.50 from $5.50 at Benchmark
- Harvard Bioscience Reports 2024 Financial Results
- Harvard Bioscience Navigates Growth Amid Challenges
- Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue